Influenza Update N° 526

Overview

Published 14 May 2025 | For reporting Week 18, ending 04 May 2025

Influenza

  • In the Northern hemisphere, influenza positivity continued to decline or remained stable in most countries. Influenza positivity remained elevated in a few countries in Central America and the Caribbean, Tropical South America, and in Western Africa (predominantly A(H1N1)pdm09), Eastern Africa and Europe (predominantly A viruses), in Western Asia (seasonal influenza viruses of all subtypes), Southern Asia (predominantly A(H3N2)), Eastern and South-East Asia (predominantly A viruses).
  • In the Southern hemisphere, influenza positivity increased or remained stable across reporting countries. Influenza positivity was elevated in Temperate South America (predominantly A(H1N1)pdm09), Southern Africa (predominantly A(H3N2)), Eastern Africa and South-East Asia (predominantly A viruses) and part of Oceania (predominantly A(H1N1)pdm09).
 

SARS-CoV-2

  • Globally, positivity continued to remain low across reporting countries except for a few countries in Central America, South-West Europe and Western Asia where positivity was elevated.
WHO encourages countries, especially those that have received the multiplex influenza and SARS-CoV-2 reagent kits from GISRS, to conduct integrated surveillance of influenza and SARS-CoV-2 and report epidemiological and laboratory information in a timely manner to established regional and global platforms. The guidance can be found here https://www.who.int/publications/i/item/WHO-2019-nCoV-integrated_sentinel_surveillance-2022.1.
 

Starting with report #501, the Global Respiratory Virus Activity Weekly Update included data from sentinel surveillance and other types of systematically conducted virologic surveillance. Countries, areas, and territories use a variety of approaches to monitor respiratory virus activity and data in this report may vary from surveillance reports posted elsewhere. Analyses stratified by source of surveillance is available through Respimart.

 

 

WHO Team
Global Influenza Programme (GIP)